|
ZNF527 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.08799996473886E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.68719998767153E-09 |
| Normal-vs-Stage2 |
2.0134000000005E-05 |
| Normal-vs-Stage3 |
1.62619999999336E-06 |
| Normal-vs-Stage4 |
1.922770E-01 |
| Stage1-vs-Stage2 |
8.497000E-01 |
| Stage1-vs-Stage3 |
5.867600E-01 |
| Stage1-vs-Stage4 |
8.135800E-01 |
| Stage2-vs-Stage3 |
7.991400E-01 |
| Stage2-vs-Stage4 |
7.659200E-01 |
| Stage3-vs-Stage4 |
6.848800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.98569996398857E-09 |
| Normal-vs-AfricanAmerican |
1.551010E-04 |
| Normal-vs-Asian |
6.09350000457809E-08 |
| Caucasian-vs-AfricanAmerican |
2.336600E-01 |
| Caucasian-vs-Asian |
1.493230E-01 |
| AfricanAmerican-vs-Asian |
4.839600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.48759959484846E-10 |
| Normal-vs-Female |
1.194550E-04 |
| Male-vs-Female |
1.757850E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.482900E-03 |
| Normal-vs-Extreme_Weight |
2.60850230304754E-11 |
| Normal-vs-Obese |
1.08139999999146E-06 |
| Normal-vs-Extreme_Obese |
8.739700E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.895600E-02 |
| Normal_Weight-vs-Obese |
6.339000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.903800E-01 |
| Extreme_Weight-vs-Obese |
2.830300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.433400E-01 |
| Obese-vs-Extreme_Obese |
8.761600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.00020000002055E-06 |
| Normal-vs-Age(41-60Yrs) |
1.55035999999109E-05 |
| Normal-vs-Age(61-80Yrs) |
1.12230003068703E-09 |
| Normal-vs-Age(81-100Yrs) |
2.27949999986876E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.335210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.189800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.631400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.960400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.499800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.431600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.99549999857496E-08 |
| Normal-VS-Type2 PRCC |
2.16530000041182E-07 |
| Normal-VS-KIRP CIMP |
2.90020000015545E-07 |
| Normal-VS-Unclassified PRCC |
3.756800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.701600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.756200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.917600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.611400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.556800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.527600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.37320044224509E-10 |
| Normal-vs-N1 |
3.126000E-02 |
| Normal-vs-N2 |
7.20610000004562E-07 |
| N0-vs-N1 |
1.905010E-01 |
| N0-vs-N2 |
1.470400E-02 |
| N1-vs-N2 |
1.077260E-03 |
|
|
